Skip to content

Standardization research of treating Chronic atrophic gastritis in weakness of spleen and stomach type by LIZHONGFUYUAN Decoction combined with acupoint application

Standardization research of treating Chronic atrophic gastritis in weakness of spleen and stomach type by LIZHONGFUYUAN Decoction combined with acupoint application

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009804
Enrollment
Unknown
Registered
2016-11-09
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Atrophic Gastritis

Interventions

A:Decoction combined with acupoint application
B:Decoction
C:folic acid

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. aged 25 to 75 years old male and female; 2. Chronic atrophic gastritis of gastric antrum was diagnosed by endoscopy; 3. Chronic atrophic gastritis of gastric antrum was diagnosed by pathologic diagnosis; 4. Confirme HP negative by C13 breath test or gastroscopy before included, or after HP radical cure(check HP negative by C13 breath test or gastroscopy after finishing western medicine combined with anti Helicobacter pylori treatment one month later); 5. TCM syndrome differentiation in weakness of spleen and stomach type; 6. No other Chinese and Western medicines were used within one month; 7. Voluntarily participated in this clinical trial and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Combined gastric and duodenal ulcer; 2. Upper gastrointestinal bleeding; 3. A high level of gastric mucosa epithelial neoplasia or suspected malignant pathological diagnosis; 4. Diabetes; 5. Severe primary heart, liver, kidney, lung, and blood system diseases, normal reference value of renal function Cr> upper limit, liver function ALT is more than or equal to the normal reference value 1.5 times; 6. Pregnancy or lactation; 7. Skin disease or skin allergies, do not cooperate with the operation; 8. Mental disease; 9. Researchers think that which are not appropriate to participate in clinical trials, including the patients who have poor compliance by researchers judgement, who can not adhere to medication for 6 months and who refuse gastroscopy after treatment.

Design outcomes

Primary

MeasureTime frame
Gastroscopy;Pathological results;Immunohistochemical results;

Countries

China

Contacts

Public ContactYan Liu

Shanghai Municipal Hospital of Traditional Chinese Medicine

0625@szy.sh.cn+86 18116070782

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026